Arrowhead Pharmaceuticals, Inc. (ARWR)
68.88
+0.28
(+0.41%)
USD |
NASDAQ |
Dec 09, 10:16
Arrowhead Pharmaceuticals Shareholders Equity (Quarterly): 466.05M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 1.320B |
| Ionis Pharmaceuticals, Inc. | 617.97M |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Amgen, Inc. | 9.619B |
| Novartis AG | 44.33B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.450B |
| Total Liabilities (Quarterly) | 947.02M |
| Debt to Equity Ratio | 1.574 |
| Current Ratio | 4.863 |
| Net Debt Paydown Yield | -1.19% |